Comments on: Oncothyreon Advances Cancer Drug http://www.xconomy.com/seattle/2009/11/12/oncothryreon-advances-cancer-drug/ Business + Technology in the Exponential Economy Sat, 11 Feb 2012 03:08:02 +0000 hourly 1 http://wordpress.org/?v=3.0.4 By: Luke Timmerman http://www.xconomy.com/seattle/2009/11/12/oncothryreon-advances-cancer-drug/comment-page-1/#comment-92198 Luke Timmerman Fri, 13 Nov 2009 20:49:08 +0000 http://www.xconomy.com/?p=50178#comment-92198 Thanks Don. I think Simos was referring to how far the company has come in the past year, which is really a long way. I'm actually thinking about doing another interview with Bob Kirkman pretty soon to try to do a good overview piece. Any questions you'd suggest? Anybody else who want to chime in, now's a good time to drop me a comment.---Luke Thanks Don. I think Simos was referring to how far the company has come in the past year, which is really a long way. I’m actually thinking about doing another interview with Bob Kirkman pretty soon to try to do a good overview piece. Any questions you’d suggest? Anybody else who want to chime in, now’s a good time to drop me a comment.—Luke

]]> By: Dr. Donald Hull http://www.xconomy.com/seattle/2009/11/12/oncothryreon-advances-cancer-drug/comment-page-1/#comment-92129 Dr. Donald Hull Fri, 13 Nov 2009 15:31:55 +0000 http://www.xconomy.com/?p=50178#comment-92129 Luke, "brink of disaster"? Strong words indeed re Oncothyreon. Some sell-side analysts need more patience so promising technology can progress through extended phase 3 trials such as the current Stimuvax work. Keep up the great reporting. Don Luke,

“brink of disaster”? Strong words indeed re Oncothyreon. Some sell-side analysts need more patience so promising technology can progress through extended phase 3 trials such as the current Stimuvax work.

Keep up the great reporting.

Don

]]>